GRDX
GridAI Technologies Corp.
NASDAQ · Healthcare · Biotechnology · US
$3.25
+9.43%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 160.3K | 36.3K | — | — | — |
| Cost of Revenue | 2.6M | 1.3M | 48.9K | — | — |
| Gross Profit | (2.5M) | (1.2M) | (48.9K) | — | — |
| Operating Expenses | |||||
| R&D Expense | 1.5M | 925.5K | 903.94 | 5.0M | 691.3K |
| SG&A Expense | 8.3M | 5.5M | 14.7M | 10.7M | 12.0M |
| General & Admin Expense | 3.3M | 5.5M | 14.7M | 10.7M | 12.0M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | (574.7K) | 903.0K | — | — |
| Total Operating Expenses | 9.8M | 5.9M | 15.6M | 15.8M | 12.7M |
| Cost and Expenses | 12.4M | 7.1M | 15.6M | 15.8M | 12.7M |
| Operating Income (EBIT) | (12.3M) | (7.1M) | (15.6M) | (15.8M) | (12.7M) |
| Non-Operating | |||||
| Interest Income | — | — | 875.00 | 2.5K | 8.4K |
| Interest Expense | 1.3M | 490.8K | — | 22.5K | 15.9K |
| Net Interest Income | (1.3M) | (490.8K) | 875.00 | (19.9K) | (7.5K) |
| Other Non-Op Income/Expense | (9.6M) | 443.4K | 2.3K | (24.2K) | (2.0M) |
| Non-Operating Income (excl Interest) | (400.3K) | — | — | — | 1.9M |
| EBT (Pre-Tax Income) | (21.8M) | (6.6M) | (15.6M) | (15.8M) | (14.6M) |
| Income Tax Expense | (751.8K) | (398.7K) | — | — | — |
| Bottom Line | |||||
| Net Income | (20.5M) | (6.4M) | (18.1M) | (15.8M) | (14.6M) |
| Earnings from Cont. Ops | (21.1M) | (6.2M) | (15.6M) | (15.8M) | (14.6M) |
| Earnings from Discont. Ops | 322.6K | (312.3K) | (2.4M) | — | — |
| Bottom Line Net Income | (20.8M) | (6.7M) | (18.3M) | (16.1M) | (15.0M) |
| Per Share | |||||
| Basic EPS | ($4.31) | ($4.16) | ($5.33) | ($143.64) | ($1,250.82) |
| Diluted EPS | ($4.31) | ($4.16) | ($5.33) | ($143.64) | ($1,250.82) |
| Revenue Per Share | $0.02 | $0.02 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 6.4M | 1.6M | 3.4M | 112113 | 11970 |
| Diluted Shares Outstanding | 6.4M | 1.6M | 3.4M | 112113 | 11970 |
| Profitability Metrics | |||||
| EBITDA | (10.1M) | (6.5M) | (15.6M) | (15.7M) | (14.6M) |
| D&A | 1.7M | 574.7K | 48.9K | 29.3K | 29.3K |
| EBIT | (11.9M) | (7.1M) | (15.6M) | (15.8M) | (14.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026